Anavex Life Sciences Corp.
AVXL
$2.76
-$0.10-3.33%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 118.33M | 127.42M | 131.75M | 102.58M | 101.16M |
| Total Receivables | 995.00K | 932.00K | 844.00K | 809.00K | 820.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 818.00K | 412.00K | 396.00K | 429.00K | 448.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 120.14M | 128.77M | 132.99M | 103.82M | 102.43M |
|
|
|||||
| Total Current Assets | 120.14M | 128.77M | 132.99M | 103.82M | 102.43M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 120.14M | 128.77M | 132.99M | 103.82M | 102.43M |
|
|
|||||
| Total Accounts Payable | 3.66M | 2.52M | 2.64M | 4.25M | 6.74M |
| Total Accrued Expenses | 4.04M | 3.73M | 2.93M | 3.37M | 3.93M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | 805.00K | 805.00K | 1.33M | 805.00K |
| Total Other Current Liabilities | -- | 805.00K | 805.00K | 1.33M | 805.00K |
| Total Current Liabilities | 7.69M | 7.06M | 6.37M | 8.95M | 11.47M |
|
|
|||||
| Total Current Liabilities | 7.69M | 7.06M | 6.37M | 8.95M | 11.47M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 7.69M | 7.06M | 6.37M | 8.95M | 11.47M |
|
|
|||||
| Common Stock & APIC | 498.09M | 515.17M | 514.75M | 477.32M | 463.58M |
| Retained Earnings | -385.64M | -393.47M | -388.13M | -382.45M | -372.62M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 112.45M | 121.71M | 126.62M | 94.87M | 90.96M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 112.45M | 121.71M | 126.62M | 94.87M | 90.96M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 112.45M | 121.71M | 126.62M | 94.87M | 90.96M |
|
|
|||||